PART I Item 1. B usiness. In this Annual Report, unless the context otherwise dictates, the terms (i) we, us, our, Sensei, the Company and other similar terms refer to the business and operations of Sensei Biotherapeutics, Inc. and its consolidated subsidiaries for periods prior to the Acquisition (as defined below) and to Sensei Biotherapeutics, Inc. and its consolidated subsidiaries, including Faeth Therapeutics for periods after the Acquisition; (ii) Faeth HoldCo refers to Faeth Holdings Ther...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001193125-26-132014 | EDGAR | 94K words |
| 2025-03-28 | 2024-12-31 | 0000950170-25-046338 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-023148 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0000950170-23-010432 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0000950170-22-003646 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001564590-21-016297 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001193125-26-331562 | EDGAR | — |
| 2025-11-14 | 2025-09-30 | 0001193125-25-281590 | EDGAR | 55K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103101 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064525 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-126748 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091895 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057106 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060340 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-038085 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019754 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023276 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016148 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001193125-26-331563 | EDGAR | — |
| 2026-07-23 | 0001193125-26-314591 | EDGAR | — |
| 2026-03-30 | 0001193125-26-130419 | EDGAR | 1K words |
| 2026-02-18 | 0001193125-26-056135 | EDGAR | — |
| 2026-02-13 | 0001193125-26-051815 | EDGAR | — |
| 2025-12-23 | 0001193125-25-331113 | EDGAR | — |
| 2025-11-14 | 0001193125-25-281581 | EDGAR | — |
| 2025-10-30 | 0001193125-25-257621 | EDGAR | — |
| 2025-10-17 | 0001193125-25-242007 | EDGAR | — |
| 2025-08-05 | 0001193125-25-173043 | EDGAR | — |
108 total filings indexed. 80 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001829802 |
| Ticker | SNSE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.senseibio.com |
| Listed | 2021-02-04 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SNSE (~200 tokens, structured JSON with cryptographic provenance)